NCT03599765 - Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor | Biotech Hunter

Enrollment

380

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Oligometastatic Malignant Solid Neoplasm

Interventions

OTHER

Best Practice

Receive routine therapy

PROCEDURE

Local Consolidation Therapy

Receive LCT

Trial Locations (12)

44903

OhioHealth Mansfield Hospital, Mansfield

49036

Community Health Center, Coldwater

72205

Baptist Health Medical Center, Little Rock

77030

M D Anderson Cancer Center, Houston

77058

MD Anderson League City, Nassau Bay

77094

MD Anderson in Katy, Houston

77384

MD Anderson in The Woodlands, The Woodlands

77478

MD Anderson in Sugar Land, Sugar Land

78229

University of Texas Health Science Center at San Antonio, San Antonio

85234

Banner MD Anderson Cancer Center, Gilbert

96813

Queen's Medical Center, Honolulu

08103

Cooper Hospital University Medical Center, Camden

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER